UnknownNCT02361411
Methods of Etiological Diagnosis of Cerebral Amyloid Angiopathy
Studying Hereditary cerebral amyloid angiopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Peking University Third Hospital
- Principal Investigator
- Dongsheng Fan, doctorPeking University Third Hospital
- Enrollment
- 1000 target
- Eligibility
- All sexes
- Timeline
- 2015 – 2017
Study locations (1)
- Peking University Third Hospital, Beijing, China
Collaborators
Beijing Municipal Science & Technology Commission
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02361411 on ClinicalTrials.govOther trials for Hereditary cerebral amyloid angiopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06714097Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- RECRUITINGPHASE2NCT05709314A Study of AMDX-2011P in Participants With CAAAmydis Inc.
- RECRUITINGPHASE2NCT06393712A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid AngiopathyAlnylam Pharmaceuticals
- RECRUITINGNCT04204642SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA)Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- ACTIVE NOT RECRUITINGNCT06128824High Frequency Imaging in Cerebral Amyloid AngiopathyMartin Dichgans